
Pacira BioSciences Inc. Sued for Alleged Securities Law Violations: An In-Depth Look
Understanding the Pacira BioSciences, Inc. Lawsuit: What Does It Mean for Investors and the World? On February 4, 2025, a press release was distributed through ACCESS Newswire announcing that a securities class action lawsuit had been filed against Pacira BioSciences, Inc. (NASDAQ: PCRX) over alleged securities law violations. The lawsuit, led by the law firm…